Meeder Asset Management’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-346
Closed 2430
2022
Q2
$0 Sell
346
-1,706
-83% -$1.5K ﹤0.01% 2501
2022
Q1
$3K Buy
+2,052
New +$1.89K ﹤0.01% 1990
2021
Q4
Sell
-1,083
Closed -$2K 2491
2021
Q3
$2K Sell
1,083
-10,836
-91% -$29.6K ﹤0.01% 2243
2021
Q2
$45K Buy
11,919
+233
+2% +$810 ﹤0.01% 1168
2021
Q1
$39K Buy
11,686
+11,263
+2,663% +$40.4K ﹤0.01% 1187
2020
Q4
$1K Sell
423
-9,631
-96% -$39.6K ﹤0.01% 1781
2020
Q3
$40K Buy
10,054
+9,608
+2,154% +$36.5K ﹤0.01% 1001
2020
Q2
$2K Sell
446
-648
-59% -$1.89K ﹤0.01% 1831
2020
Q1
$3K Buy
1,094
+133
+14% +$364 ﹤0.01% 2017
2019
Q4
$3K Buy
961
+757
+371% +$6.12K ﹤0.01% 1963
2019
Q3
$2K Buy
+204
New +$1.65K ﹤0.01% 2009
2019
Q2
Sell
-154
Closed -$2K 2182
2019
Q1
$2K Sell
154
-591
-79% -$6.33K ﹤0.01% 1589
2018
Q4
$7K Sell
745
-6,449
-90% -$82.1K ﹤0.01% 1344
2018
Q3
$122K Buy
7,194
+1,746
+32% +$37.8K 0.01% 602
2018
Q2
$114K Buy
5,448
+3,123
+134% +$57.9K 0.01% 602
2018
Q1
$38K Buy
2,325
+264
+13% +$5.23K ﹤0.01% 742
2017
Q4
$39K Buy
2,061
+1,218
+144% +$22.1K ﹤0.01% 748
2017
Q3
$12K Sell
843
-1,132
-57% -$10.2K ﹤0.01% 1041
2017
Q2
$15K Buy
1,975
+484
+32% +$3.16K ﹤0.01% 893
2017
Q1
$10K Sell
1,491
-563
-27% -$3.15K ﹤0.01% 865
2016
Q4
$9K Buy
+2,054
New +$8.62K ﹤0.01% 778

Other funds holding SPPI

Meeder Asset Management's SPPI Position: Q3 2022 in Review

Meeder Asset Management sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q3 2022, closing a stake of 346 shares.

Meeder Asset Management first reported a position in SPPI in Q4 2016 and held it in 21 quarters. The position peaked at $122K in Q3 2018. 75 funds tracked by Wall St. Rank hold SPPI as of Q3 2022.

  • Meeder Asset Management reported no remaining Spectrum Pharmaceuticals Inc position as of Q3 2022 after selling out during the quarter.
  • Meeder Asset Management sold 346 Spectrum Pharmaceuticals Inc shares in Q3 2022.
  • Meeder Asset Management first reported a position in Spectrum Pharmaceuticals Inc in Q4 2016 and held it in 21 quarters.
  • Meeder Asset Management's Spectrum Pharmaceuticals Inc position peaked at $122K in Q3 2018.
  • 75 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q3 2022.

Based on Meeder Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.